PL2440073T3 - Synergistyczna mieszanina beta-galakto-oligosacharydów z wiązaniami beta-1,3 i beta-1,4/1,6 - Google Patents

Synergistyczna mieszanina beta-galakto-oligosacharydów z wiązaniami beta-1,3 i beta-1,4/1,6

Info

Publication number
PL2440073T3
PL2440073T3 PL10730564T PL10730564T PL2440073T3 PL 2440073 T3 PL2440073 T3 PL 2440073T3 PL 10730564 T PL10730564 T PL 10730564T PL 10730564 T PL10730564 T PL 10730564T PL 2440073 T3 PL2440073 T3 PL 2440073T3
Authority
PL
Poland
Prior art keywords
beta
galacto
oligosaccharides
linkages
synergistic mixture
Prior art date
Application number
PL10730564T
Other languages
English (en)
Inventor
Bernd Stahl
Alma Jildou Nauta
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41479409&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2440073(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2440073T3 publication Critical patent/PL2440073T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pediatric Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL10730564T 2009-06-12 2010-06-14 Synergistyczna mieszanina beta-galakto-oligosacharydów z wiązaniami beta-1,3 i beta-1,4/1,6 PL2440073T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2009/050331 WO2010143940A1 (en) 2009-06-12 2009-06-12 Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
EP10730564.1A EP2440073B1 (en) 2009-06-12 2010-06-14 Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
PCT/NL2010/050364 WO2010143961A1 (en) 2009-06-12 2010-06-14 Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages

Publications (1)

Publication Number Publication Date
PL2440073T3 true PL2440073T3 (pl) 2014-01-31

Family

ID=41479409

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10730564T PL2440073T3 (pl) 2009-06-12 2010-06-14 Synergistyczna mieszanina beta-galakto-oligosacharydów z wiązaniami beta-1,3 i beta-1,4/1,6

Country Status (9)

Country Link
US (1) US8591919B2 (pl)
EP (1) EP2440073B1 (pl)
CN (1) CN102458152B (pl)
BR (1) BRPI1010709A2 (pl)
ES (1) ES2431936T3 (pl)
MY (1) MY155627A (pl)
PL (1) PL2440073T3 (pl)
RU (1) RU2529160C2 (pl)
WO (2) WO2010143940A1 (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9119414B2 (en) 2007-12-07 2015-09-01 N.V. Nutricia Bifidobacterium for dust mite allergy
BR112012000859B1 (pt) 2009-07-15 2021-08-03 N.V. Nutricia Uso de 2'-fucosilactose na fabricação de uma composição enteral
ES2989649T3 (es) * 2009-07-15 2024-11-27 Nutricia Nv Mezcla de oligosacáridos no digeribles para estimular el sistema inmunitario
WO2011149335A1 (en) * 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
AR087157A1 (es) 2011-06-20 2014-02-26 Gen Biscuit Galletita saludable
PT3366143T (pt) 2011-06-20 2025-01-07 Heinz Co Brands H J Llc Composições e métodos probióticos
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CN104039175A (zh) * 2011-10-24 2014-09-10 N·V·努特里奇亚 使用非消化性低聚糖的变态反应疗法
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP3470074B1 (en) 2013-05-10 2020-10-14 H.J. Heinz Company Brands LLC Probiotics
CN111471117A (zh) 2014-07-09 2020-07-31 卡德纳生物有限公司 低聚糖组合物及其制备方法
PL3193901T3 (pl) 2014-12-23 2018-10-31 4D Pharma Research Limited Polipeptyd pyrynowy i immunomodulacja
CN113862175A (zh) 2014-12-23 2021-12-31 4D制药研究有限公司 免疫调控
CA2975095A1 (en) 2015-01-26 2016-08-04 Cadena Bio, Inc. Oligosaccharide compositions for use as animal feed and methods of producing thereof
WO2016172657A2 (en) 2015-04-23 2016-10-27 Kaleido Biosciences, Inc. Glycan therapeutics and methods of treatment
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
RS59446B1 (sr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Blautia stercosis i wexlerae za upotrebu u lečenju inflamatornih i autoimunskih bolesti
MD3206700T2 (ro) 2015-06-15 2019-12-31 4D Pharma Res Ltd Compoziții conținând tulpini bacteriene
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PE20180267A1 (es) 2015-06-15 2018-02-06 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2017085520A1 (en) 2015-11-20 2017-05-26 4D Pharma Research Limited Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
JP6441536B2 (ja) 2016-03-04 2018-12-19 フォーディー ファーマ ピーエルシー４Ｄ Ｐｈａｒｍａ Ｐｌｃ 細菌株を含む組成物
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
HUE054164T2 (hu) 2017-05-22 2021-08-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
WO2018215782A1 (en) 2017-05-24 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strain
LT3600363T (lt) 2017-06-14 2021-02-10 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
MA49010B1 (fr) 2017-06-14 2020-11-30 4D Pharma Res Ltd Compositions comprenant une souche bactérienne du genre megasphaera et leurs utilisations
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
WO2019031961A1 (en) 2017-08-11 2019-02-14 N.V. Nutricia OLIGOSACCHARIDE OF HUMAN MILK TO IMPROVE PHYSICAL IMMUNE CONDITION
TW202023590A (zh) 2018-08-17 2020-07-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
PH12021552677A1 (en) * 2019-05-15 2022-07-04 Nutricia Nv Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
EP4114841A1 (en) * 2020-03-04 2023-01-11 FrieslandCampina Nederland B.V. Galacto-oligosaccharide having a terminal mannose residue, its preparation and application
US20230165881A1 (en) * 2020-04-30 2023-06-01 Kaleido Biosciences, Inc. Oligosaccharide compositions and methods of use thereof for treating viral infections
WO2022233855A1 (en) 2021-05-03 2022-11-10 N.V. Nutricia Galactooligosaccharides for improving immune response
US20250332182A1 (en) * 2021-05-03 2025-10-30 N.V. Nutricia Galactooligosaccharides for improving immune response
GB2619977A (en) * 2022-06-24 2023-12-27 Clasado Res Services Limited Compositions and uses thereof
AU2024244409A1 (en) * 2023-04-05 2025-10-23 Dsm Ip Assets B.V. Oligosaccharide preparation counteracting respiratory disease effect

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723963B1 (fr) 1994-08-31 1997-01-17 Gervais Danone Co Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase
FR2723960B1 (fr) 1994-08-31 1996-10-11 Gervais Danone Co Cultures de streptococcus thermophilus a activite beta-galactosidase elevee, leur procede d'obtention, et leurs utilisations
FR2795917B1 (fr) 1999-07-06 2001-08-31 Gervais Danone Sa Procede de preparation d'un produit lacte immunostimulant et ses applications
BR0108828A (pt) 2000-03-01 2002-12-10 Nestle Sa Formulação de carboidrato (adjuvante pré-biótico) para aperfeiçoamento de resposta imuno
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
DE602004006133T3 (de) 2003-06-30 2014-12-24 Clasado Inc. Neue galactooligosaccharidzusammensetzung und herstellung davon
NZ546785A (en) 2003-10-24 2009-07-31 Nutricia Nv Immunemodulating oligosaccharides
CN1870910B (zh) 2003-10-24 2010-05-26 努特里奇亚有限公司 婴儿合生素组合物
PL2258219T5 (pl) * 2005-04-27 2023-03-06 N.V. Nutricia Żywienie za pomocą lipidów i niestrawnych sacharydów
WO2007067033A1 (en) 2005-12-06 2007-06-14 N.V. Nutricia Composition containing oligosaccharides for the treatment/ prevention of infections
PL1993576T3 (pl) * 2006-03-07 2016-04-29 Nestec Sa Mieszanina synbiotyczna

Also Published As

Publication number Publication date
WO2010143940A1 (en) 2010-12-16
MY155627A (en) 2015-11-13
ES2431936T3 (es) 2013-11-28
CN102458152A (zh) 2012-05-16
RU2012100719A (ru) 2013-07-20
BRPI1010709A2 (pt) 2015-09-15
CN102458152B (zh) 2013-10-30
US20120141541A1 (en) 2012-06-07
RU2529160C2 (ru) 2014-09-27
US8591919B2 (en) 2013-11-26
EP2440073A1 (en) 2012-04-18
EP2440073B1 (en) 2013-07-31
WO2010143961A1 (en) 2010-12-16

Similar Documents

Publication Publication Date Title
PL2440073T3 (pl) Synergistyczna mieszanina beta-galakto-oligosacharydów z wiązaniami beta-1,3 i beta-1,4/1,6
IL256921A (en) Pyrazolopyrimidines, pharmaceutical preparations containing them and their use
PL2513023T3 (pl) Kompozycje i zastosowania cis-1,1,1,4,4,4-heksafluoro-2-butenu
IL222573A0 (en) Stabilized fibronectin domain compositions, methods and uses
ZA201200254B (en) Certain chemical entities,compositions and methods
EP2068798A4 (en) METHODS, COMPOSITIONS AND APPARATUSES FOR TREATING INJURIES USING ALTERED PRESSURES FROM ATMOSPHERIC PRESSURES
IL220283A0 (en) 4-oxo-ih-quinoline-3- carboxamides, compositions comprising the same and uses thereof
IL209188A (en) Sweetener, preparations containing it and methods of manufacture
HUE047698T2 (hu) 2,3,3,3-tetrafluorpropént és 2,3-diklór-3,3-difluorpropént tartalmazó kompozíciók
IL215684A0 (en) Trehalulose-containing composition, its preparation and use
EP2499195A4 (en) Oxygen scavengers, compositions comprising the scavengers, and artcles made from the compositions
EP2445067A4 (en) COMPOSITION FOR FILLING THE DISCHARGE GAP AND ELECTROSTATIC DISCHARGE PROTECTION
GB0903299D0 (en) Composition and methods
IL211204A0 (en) Mucoadherents compositions and their use
ZA201202482B (en) Synergistic antiviral composition and use thereof
PL2646520T3 (pl) Kompozycja na bazie 1,1,1,4,4,4-heksafluorobut-2-enu i 3,3,4,4,4-pentafluorobut-1-enu
ZA201103065B (en) Preservation mixture and use thereof
IL215980A (en) An intermediate substance of Artemnam, a preparation containing it and methods for its preparation
GB0902429D0 (en) Compositions and their use
IL214757A0 (en) Compositions and methods to prevent and/or treat cancer with pa-card
ZA201101853B (en) Fuel compositions comprising limonane and farnesane
GB0909792D0 (en) Composition and uses thereof
GB0901899D0 (en) Compositions and uses
GB0922735D0 (en) Improvements in or relating to laparoscopic trocars and cannulae
GB0902812D0 (en) Composition and use